Entity Common Stock, Shares Outstanding of BioRestorative Therapies, Inc. from Q3 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioRestorative Therapies, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2011 to Q3 2025.
  • BioRestorative Therapies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 8,876,242, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BioRestorative Therapies, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 8,876,242 +1,956,323 +28% 11 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 7,978,117 +1,208,198 +18% 11 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 7,504,780 +734,861 +11% 26 Mar 2025 10-K 28 Mar 2025 2024 FY
Q3 2024 6,919,919 +2,213,002 +47% 12 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 6,769,919 +2,102,278 +45% 10 Jun 2024 10-Q 11 Jun 2024 2024 Q1
Q1 2024 6,769,919 +3,002,304 +80% 28 Mar 2024 10-K/A 06 Nov 2024 2023 FY
Q3 2023 4,706,917 +1,033,288 +28% 10 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 4,667,641 +1,021,755 +28% 08 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 3,767,615 +141,012 +3.9% 22 Mar 2023 10-K 27 Mar 2023 2022 FY
Q3 2022 3,673,629 +180,644 +5.2% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 3,645,886 -3,347,198,559 -100% 08 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 3,626,603 -3,021,403,107 -100% 28 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 3,492,985 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 3,350,844,445 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 3,025,029,710 26 Mar 2021 10-Q 29 Mar 2021 2020 Q1
Q3 2019 30,761,527 +20,307,591 +194% 11 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 21,410,146 +14,202,590 +197% 14 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 14,676,794 +8,193,541 +126% 27 Mar 2019 10-K 29 Mar 2019 2018 FY
Q3 2018 10,453,936 +4,795,080 +85% 12 Nov 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 7,207,556 +1,635,878 +29% 13 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 6,483,253 +1,207,226 +23% 29 Mar 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 5,658,856 +1,101,426 +24% 14 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 5,571,678 +1,288,043 +30% 11 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 5,276,027 +1,350,209 +34% 15 Mar 2017 10-K 22 Mar 2017 2016 FY
Q3 2016 4,557,430 08 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 4,283,635 +1,457,311 +52% 12 Aug 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 3,925,818 -33,223,234 -89% 28 Mar 2016 10-K 30 Mar 2016 2015 FY
Q4 2015 3,133,329 19 Nov 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 2,826,324 -23,977,031 -89% 12 Aug 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 37,149,052 +15,316,038 +70% 30 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 31,457,869 +14,298,091 +83% 11 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 26,803,355 08 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 21,833,014 -798,807,997 -97% 09 Apr 2014 10-K 11 Apr 2014 2013 FY
Q3 2013 17,159,778 -705,394,633 -98% 14 Nov 2013 10-Q 19 Nov 2013 2013 Q3
Q1 2013 820,641,011 +172,649,100 +27% 28 Mar 2013 10-K 02 Apr 2013 2012 FY
Q3 2012 722,554,411 +155,726,400 +27% 01 Nov 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 684,579,411 09 Aug 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 647,991,911 10 Apr 2012 10-K 16 Apr 2012 2011 FY
Q4 2011 602,626,111 17 Nov 2011 10-Q 21 Nov 2011 2011 Q3
Q3 2011 566,828,011 17 Aug 2011 10-Q/A 14 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.